CN Patent

CN101353368A — 一种治疗肿瘤的孕甾药物

Assigned to TIANJIN PHARMACEUTICALS GROUP CORP · Expires 2009-01-28 · 17y expired

What this patent protects

本发明属于医药领域，特别涉及式(I)化合物及其合成方法。本发明也涉及该化合物在药物上的用途和药用制剂，特别是针对肿瘤、眼部血管新生的治疗。

USPTO Abstract

本发明属于医药领域，特别涉及式(I)化合物及其合成方法。本发明也涉及该化合物在药物上的用途和药用制剂，特别是针对肿瘤、眼部血管新生的治疗。

Drugs covered by this patent

Patent Metadata

Patent number
CN101353368A
Jurisdiction
CN
Classification
—
Expires
2009-01-28
Drug substance claim
No
Drug product claim
No
Assignee
TIANJIN PHARMACEUTICALS GROUP CORP
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.